Drugs / ABT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04006353 | Jul → Sep 2019 | — | Shanghai Public Health Clinical Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04006353 ↗ |
| Route | Intravenous | “Intravenous infusion of 320 mg ABT on Day 1, 2, 3, and 8.” NCT04006353 ↗ |